JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Neuza Helena Lopes
Noedir Stolf
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Lopes, N. H.
Right arrow Articles by Hueb, W.
PubMed
Right arrow Articles by Lopes, N. H.
Right arrow Articles by Hueb, W.
Related Collections
Right arrow Coronary disease

J Thorac Cardiovasc Surg 2009;137:1443-1449
© 2009 The American Association for Thoracic Surgery


Acquired Cardiovascular Disease

Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease

Neuza Helena Lopes, MD, PhD*, Felipe da Silva Paulitsch, MD, Alexandre Pereira, MD, PhD, Cibele Larossa Garzillo, MD, João Fernando Ferreira, MD, PhD, Noedir Stolf, MD, PhD, Whady Hueb, MD, PhD

Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil

Received for publication July 24, 2008; revisions received October 21, 2008; accepted for publication November 19, 2008.

* Address for reprints: Neuza Helena Lopes, MD, PhD, Av D. Enéas de Carvalho Aguiar # 44, sala 114. Cerqueira Cesar, São Paulo-SP/ Brazil 05403-000. (Email: mass{at}incor.usp.br).

Objective: Our objective was to evaluate the association of chronic kidney dysfunction in patients with multivessel chronic coronary artery disease, preserved left ventricular function, and the possible interaction between received treatment and cardiovascular events.

Methods: The glomerular filtration rate was determined at baseline on 611 patients who were randomized into three treatment groups: medical treatment, percutaneous coronary intervention, and coronary artery bypass surgery. Incidence of myocardial infarction, angina requiring a new revascularization procedure, and death were analyzed during 5 years in each group.

Results: Of 611 patients, 112 (18%) were classified as having normal renal function, 349 (57%) were classified as having mild dysfunction, and 150 (25%) were classified as having moderate dysfunction. There were significant differences among the cumulative overall mortality curves among the three renal function groups. Death was observed more frequently in the moderate dysfunction group than the other two groups (P < .001). Interestingly, in patients with mild chronic kidney dysfunction, we observed that coronary artery bypass treatment presented a statistically higher percentage of event-free survival and lower percentage of mortality than did percutaneous coronary intervention or medical treatment

Conclusions: Our results confirm that coronary artery disease accompanied by chronic kidney dysfunction has a worse prognosis, regardless of the therapeutic strategy for coronary artery disease, when renal function is at least mildly impaired. Additionally, our data suggest that the different treatment strategies available for stable coronary artery disease may have differential beneficial effects according to the range of glomerular filtration rate strata.



Abbreviations and Acronyms APPROACH = Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease; CABG = coronary artery bypass grafting; CAD = coronary artery disease; CI = confidence interval; CKD = chronic kidney dysfunction; eGFR = estimated glomerular filtration rate; HDL = high-density lipoprotein; MASS II = Medicine, Angioplasty, or Surgery Study; MDRD = Modification of Diet in Renal Disease; MI = myocardial infarction; MT = medical treatment; NKF = National Kidney Foundation; PCI = percutaneous coronary intervention; PRESTO = Results of Prevention of REStenosis with Tranilast and its Outcomes; RF = renal function; RR = relative risk








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.